These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34102966)

  • 1. Cannabinoids and Myocardial Ischemia: Novel insights, Updated Mechanisms, and Implications for Myocardial Infarction.
    Seif El Dahan K; Machtoub D; Massoud G; Nasser SA; Hamam B; Kobeissy F; Zouein FA; Eid AH
    Curr Med Chem; 2022; 29(11):1990-2010. PubMed ID: 34102966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?
    Weresa J; Pędzińska-Betiuk A; Mińczuk K; Malinowska B; Schlicker E
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Synthetic cannabis': A dangerous misnomer.
    Darke S; Banister S; Farrell M; Duflou J; Lappin J
    Int J Drug Policy; 2021 Dec; 98():103396. PubMed ID: 34343944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic changes induced by cannabinoid drugs and cannabis use disorder.
    Augustin SM; Lovinger DM
    Neurobiol Dis; 2022 Jun; 167():105670. PubMed ID: 35219856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Properties of the Plant-Derived Natural products Cannabinoids and Implications for Cardiovascular Health.
    Liberale L; Montecucco F; Carbone F
    Adv Exp Med Biol; 2021; 1308():249-255. PubMed ID: 33861448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and cannabinoids: pharmacology and therapeutic potential.
    Śmiarowska M; Białecka M; Machoy-Mokrzyńska A
    Neurol Neurochir Pol; 2022; 56(1):4-13. PubMed ID: 35133644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
    Krebs MO; Kebir O; Jay TM
    Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Proteomic View of Cellular and Molecular Effects of Cannabis.
    Abyadeh M; Gupta V; Paulo JA; Gupta V; Chitranshi N; Godinez A; Saks D; Hasan M; Amirkhani A; McKay M; Salekdeh GH; Haynes PA; Graham SL; Mirzaei M
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids and atherosclerotic coronary heart disease.
    Singla S; Sachdeva R; Mehta JL
    Clin Cardiol; 2012 Jun; 35(6):329-35. PubMed ID: 22278660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Complications of Marijuana and Related Substances: A Review.
    Singh A; Saluja S; Kumar A; Agrawal S; Thind M; Nanda S; Shirani J
    Cardiol Ther; 2018 Jun; 7(1):45-59. PubMed ID: 29218644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
    Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
    Rodriguez CEB; Ouyang L; Kandasamy R
    Behav Pharmacol; 2022 Apr; 33(2&3):130-157. PubMed ID: 33709984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor mechanisms underlying the CNS effects of cannabinoids: CB
    Hempel B; Xi ZX
    Adv Pharmacol; 2022; 93():275-333. PubMed ID: 35341569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis.
    Jacobson MR; Watts JJ; Boileau I; Tong J; Mizrahi R
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):330-348. PubMed ID: 30635160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use.
    Richards JR
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):508-522. PubMed ID: 32588641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid signaling in health and disease.
    Lu Y; Anderson HD
    Can J Physiol Pharmacol; 2017 Apr; 95(4):311-327. PubMed ID: 28263083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis-associated myocardial infarction in a young man with normal coronary arteries.
    Hodcroft CJ; Rossiter MC; Buch AN
    J Emerg Med; 2014 Sep; 47(3):277-81. PubMed ID: 24996293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.